Warfarin Treatment in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease Sins of Omission or Commission?

被引：12
|
作者：
Winkelmayer, Wolfgang C. [1 ,2 ]
Turakhia, Mintu P. [3 ,4 ]
机构：
[1] Stanford Univ, Sch Med, Div Nephrol, Dept Med, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA
[4] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 311卷 / 09期
关键词：
ORAL ANTICOAGULATION; RISK-FACTORS; STROKE; PREVENTION; HEMORRHAGE; TRIAL;
D O I：
10.1001/jama.2014.1781
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：913 / 915
页数：3
相关论文
共 50 条
  • [21] Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues
    Matusi, Pawel T.
    Heleniak, Zbigniew
    Undas, Anetta
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2022, 26 (12) : 857 - 863
  • [22] Secondary Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation and Advanced Chronic Kidney Disease
    Ren, Yanzhao
    Miao, Menglong
    Tan, Ruopeng
    Xu, Guiwen
    Liu, Yang
    Yin, Xiaomeng
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2025,
  • [23] Anticoagulants in atrial fibrillation patients with chronic kidney disease
    Hart, Robert G.
    Eikelboom, John W.
    Ingram, Alistair J.
    Herzog, Charles A.
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (10) : 569 - 578
  • [24] Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation
    Carrero, Juan Jesus
    Evans, Marie
    Szummer, Karolina
    Spaak, Jonas
    Lindhagen, Lars
    Edfors, Robert
    Stenvinkel, Peter
    Jacobson, Stefan H.
    Jernberg, Tomas
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (09): : 919 - 928
  • [25] Bleeding Complications Associated with Warfarin Treatment in Ischemic Stroke Patients with Atrial Fibrillation: A Population-Based Cohort Study
    Seet, Raymond C. S.
    Rabinstein, Alejandro A.
    Christianson, Teresa J. H.
    Petty, George W.
    Brown, Robert D., Jr.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (04) : 561 - 569
  • [26] Atrial fibrillation in chronic kidney disease
    Voroneanu, Luminita
    Ortiz, Alberto
    Nistor, Ionut
    Covic, Adrian
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 3 - 13
  • [27] Atrial fibrillation and chronic kidney disease
    Dabrowski, Piotr
    Mizia-Stec, Katarzyna
    Chudek, Jerzy
    KARDIOLOGIA POLSKA, 2011, 69 (02) : 167 - 172
  • [28] PREVALENCE OF ADVANCED CHRONIC KIDNEY DISEASE IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION HOSPITALIZED IN CARDIOLOGY DEPARTMENTS
    Chashkina, M., I
    Kozlovskaya, N. L.
    Andreev, D. A.
    Ananicheva, N. A.
    Bykova, A. A.
    Salpagarova, Z. K.
    Syrkin, A. L.
    KARDIOLOGIYA, 2020, 60 (02) : 41 - 46
  • [29] Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney disease
    Weir, Matthew R.
    Ashton, Veronica
    Moore, Kenneth T.
    Shrivastava, Shubham
    Peterson, Eric D.
    Ammann, Eric M.
    AMERICAN HEART JOURNAL, 2020, 223 : 3 - 11
  • [30] Oral anticoagulation in chronic kidney disease with atrial fibrillation
    Exposito, Victor
    Seras, Miguel
    Fernandez-Fresnedo, Gema
    MEDICINA CLINICA, 2015, 144 (10): : 452 - 456
12345